Antibodies
10 December 2013
Seattle Genetics Highlights Data from Broad ADCETRIS® (Brentuximab Vedotin) Development Program at ASH 20139 December 2013
Dyax Presents Investigational DX-2930 and Biomarker Assay Data at the 2013 American Society of Hematology Annual Meeting9 December 2013
ImmunoGen, Inc. Announces Favorable Initial Safety and Response Findings for CD38-Targeting Anticancer Compound, SAR6509848 December 2013
NKT Therapeutics Reports First Clinical Results with anti-iNKT Antibody in Patients with Sickle Cell Disease8 December 2013
Siltuximab Pivotal Trial Data Show Efficacy for Treatment of Patients with Multicentric Castleman’s Disease8 December 2013
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2015 December 2013
European Medicines Agency Approves Once Every Two Weeks Dosing Option For Hizentra®▼ (Human Normal Immunoglobulin, SCIg)5 December 2013
Apogenix’ APG350 Effectively Induces Apoptosis of Tumor Cells via TRAIL Pathway Independent of Fc-gamma Cross-Linking28 November 2013
Bayer Submits VEGF Trap-Eye (aflibercept solution for injection) for the Treatment of Myopic Choroidal Neovascularization in Japan26 November 2013
Merrimack Pharmaceuticals’ MM-121 Demonstrates Positive Signal in Two Phase 2 ER/PR+ Breast Cancer Studies25 November 2013
Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX(TM) for the Maintenance Therapy of Ovarian Carcinoma22 November 2013
Merck announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors22 November 2013
EYLEA® (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan22 November 2013
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports